Neutronfarma sold pills that treated everything — even COVID-19. Indecopi fined it

Neutronfarma E.I.R.L. marketed two products with a growing list of cures. 'Baisser Ener-Gython Magnesio + Aloe Vera' was advertised as supporting the renal, cardiac, nervous and muscular systems, regulating blood pressure, preventing anemia and fighting infections — and as a treatment for neurological and eye conditions, even COVID-19. 'Krischman' promised immune-system benefits and treatment of diabetes, anemia, infections and more than 34 other pathologies, including for pregnant women.

None of it was backed by evidence. Indecopi's Unfair Competition Commission sanctioned the company 2.19 UIT per product — 4.38 UIT in total, S/24,090 — and the Competition Defense Chamber confirmed both rulings on second instance in March 2026 (Resolutions 0034-2026/SDC and 031-2026/SDC). The corrective measures: definitive removal of the advertising and registration in the Registry of Offenders.

The cure-all logic is its own refutation: the more a single product promises, the less each promise is believed — and the regulator counts the infractions per product. A therapeutic claim without evidence is the violation itself, not embellishment.